Answer
Yes, serious venous thromboembolic events, including pulmonary embolism, some fatal, and deep vein thrombosis have been observed in patients taking tofacitinib citrate.
Sources for this answer
- XELJANZ 5mg film-coated tabletsPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 33Document updated
Sources checked